Literature DB >> 11578997

Residual symptoms and impairment in major depression in the community.

R Mojtabai1.   

Abstract

OBJECTIVE: Studies of patients with major depression in treatment settings have found significant residual symptoms and impairment after resolution of the depressive episode. However, only a small proportion of individuals with major depression seek treatment, and little is known about the residual symptoms and impairment associated with major depression in the community. This study used data from the National Comorbidity Survey, which included a nationally representative household sample of respondents in the United States, to assess the course of residual symptoms and impairment after resolution of major depressive episodes in the community.
METHOD: National Comorbidity Survey respondents with lifetime major depression who were currently experiencing a major depressive episode and respondents whose last episode had ended more than 1 to 6 months, more than 6 to 12 months, or more than 12 months ago were compared with those without a history of major depression with regard to depressive symptoms and days of impairment in work functioning or other activities in the past 30 days.
RESULTS: Respondents whose last episode of major depression had resolved even more than a year ago were still more symptomatic than those without a history of major depression, whereas the number of days of impairment returned to a level indistinguishable from that of respondents without a history of major depression after >6 to 12 months of resolution of the last episode.
CONCLUSIONS: Major depression in the community, as in treatment settings, is associated with residual symptoms and impairment. In the community, however, residual impairment may resolve more quickly than residual symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11578997     DOI: 10.1176/appi.ajp.158.10.1645

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Falling through the cracks: gaps in depression treatment among older Mexican-origin and white men.

Authors:  Ladson Hinton; Ester Carolina Apesoa-Varano; Hector M González; Sergio Aguilar-Gaxiola; Megan Dwight-Johnson; Judith C Barker; Cindy Tran; Ramiro Zuniga; Jürgen Unützer
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-01       Impact factor: 3.485

2.  National trends in mental health disability, 1997-2009.

Authors:  Ramin Mojtabai
Journal:  Am J Public Health       Date:  2011-09-22       Impact factor: 9.308

Review 3.  Transforming mental health services to address gender disparities in depression risk factors.

Authors:  Karen Whiteman; Nicole Ruggiano; Barbara Thomlison
Journal:  J Women Aging       Date:  2016-07-08

4.  Attentional bias modification is associated with fMRI response toward negative stimuli in individuals with residual depression: a randomized controlled trial

Authors:  Eva Hilland; Nils I. Landrø; Catherine J. Harmer; Michael Browning; Luigi A. Maglanoc; Rune Jonassen
Journal:  J Psychiatry Neurosci       Date:  2020-01-01       Impact factor: 6.186

5.  Disability associated with mental disorders in metropolitan China: an application of the quantile regression approach.

Authors:  Hui Green Cheng; Yue-Qin Huang; Zhaorui Liu; Mingyuan Zhang; Sing Lee; Yucun Shen; Yanling He; James Christopher Anthony; Ronald C Kessler
Journal:  Psychiatry Res       Date:  2012-04-10       Impact factor: 3.222

6.  Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder.

Authors:  Alan M Langlieb; Christine J Guico-Pabia
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

7.  Midline and right frontal brain function as a physiologic biomarker of remission in major depression.

Authors:  Ian A Cook; Aimee M Hunter; Michelle Abrams; Barbara Siegman; Andrew F Leuchter
Journal:  Psychiatry Res       Date:  2009-10-22       Impact factor: 3.222

8.  Lifetime history of depression and anxiety disorders as a predictor of quality of life in midlife women in the absence of current illness episodes.

Authors:  Hadine Joffe; Yuefang Chang; Sammy Dhaliwal; Rachel Hess; Rebecca Thurston; Ellen Gold; Karen A Matthews; Joyce T Bromberger
Journal:  Arch Gen Psychiatry       Date:  2012-05

9.  Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report.

Authors:  A A Nierenberg; M M Husain; M H Trivedi; M Fava; D Warden; S R Wisniewski; S Miyahara; A J Rush
Journal:  Psychol Med       Date:  2009-05-22       Impact factor: 7.723

Review 10.  The Impact of Residual Symptoms in Major Depression.

Authors:  Joshua A Israel
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.